Re: Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

Eur Urol. 2024 Apr;85(4):397. doi: 10.1016/j.eururo.2023.11.022. Epub 2023 Dec 11.
No abstract available

MeSH terms

  • Benzamides
  • Humans
  • Male
  • Nitriles
  • Phenylthiohydantoin / therapeutic use
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy

Substances

  • enzalutamide
  • Nitriles
  • Phenylthiohydantoin
  • Benzamides